Yan-jun Zhang

发表

PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species.

Yahui Ding, Ming Yang, D. Xiong, 2013, European journal of pharmacology.

Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.

Xiaolong Zhang, Y. Ru, D. Xiong, 2016, Cancer letters.

Bispecific CD3-HAC carried by E1A-engineered mesenchymal stromal cells against metastatic breast cancer by blocking PD-L1 and activating T cells

Jianxiang Wang, Xiaolong Zhang, M. Hao, 2019, Journal of Hematology & Oncology.

Sorcin silencing inhibits epithelial-to-mesenchymal transition and suppresses breast cancer metastasis in vivo

Yun-hui Hu, E. Yagüe, Ming Yang, 2013, Breast Cancer Research and Treatment.

Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan

Xiaolong Zhang, D. Xiong, Leisheng Zhang, 2017, Journal of Hematology & Oncology.

A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer

Jianxiang Wang, M. Hao, D. Xiong, 2021, Frontiers in Oncology.

E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice

Zong-fang Li, Xiaolong Zhang, Hongbo R. Luo, 2016, Oncotarget.

Surface expression of anti‐CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A‐engineered human umbilical cord mesenchymal stem cells

Xiao-Long Zhang, Yang Lu, D. Fan, 2017, International journal of cancer.

Down‐regulation of c‐fos by shRNA sensitizes adriamycin‐resistant MCF‐7/ADR cells to chemotherapeutic agents via P‐glycoprotein inhibition and apoptosis augmentation

Xiuli Zhang, D. Xiong, Hongwei Peng, 2013, Journal of cellular biochemistry.

A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.

Rong Liu, Xiuli Zhang, Yin-liang Xie, 2011, European journal of pharmacology.

Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin's lymphoma.

Hongwei Peng, Dongsheng Xiong, Ming Yang, 2013, Molecular pharmaceutics.

The novel structure make LDM effectively remove CD123+ AML stem cells in combination with interleukin 3

J. Qian, Jianxiang Wang, Rong Liu, 2015, Cancer biology & therapy.

Efficient Inhibition of Human B-cell Lymphoma in SCID Mice by Synergistic Antitumor Effect of Human 4-1BB Ligand/Anti-CD20 Fusion Proteins and Anti-CD3/Anti-CD20 Diabodies

Zhen-ping Zhu, Rong Liu, Wenguo Jiang, 2010, Journal of immunotherapy.

A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma

Jianxiang Wang, Xiaomin Lei, Xiaolong Zhang, 2021, Journal of immunotherapy.

Gene therapy in B-NHL cell line using adenovirus-mediated transfer of secretable trimeric TRAIL gene expression driven by CD20 promoter.

Ming Yang, Yalong Ding, Hongwei Peng, 2013, Experimental hematology.

Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.

Jianxiang Wang, Ming Yang, D. Xiong, 2014, Biomaterials.

Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.

Jianxiang Wang, Ming Yang, D. Xiong, 2014, Biomaterials.